The potential blockbuster drug was approved by the agency more than a month before its scheduled decision date. A potential blockbuster cancer drug developed by Genentech Inc. and parent company ...

Swiss drug makers Lonza and Roche agreed in March ... S) completed its $1.2 billion purchase of Genentech’s Vacaville campus, considered home of the world’s largest biopharmaceutical ...

Roche Group unit Genentech said that the Food and Drug Administration approved Itovebi for treating certain breast cancer. The approval is for Itovebi in combination with palbociclib and ...

You can also read Eli Lilly chief scientist Daniel M. Skovronsky on fallacies surrounding patents, drug discovery, and affordability, Sandoz CEO Richard Saynor on what the 2024 conversation is ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that it will present more than 40 ...

--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today positive topline ...

Genentech Inc. didn’t need to wait until Thanksgiving for the U.S. FDA to make up its mind. More than a month ahead of its PDUFA date, the agency approved the firm’s first-line breast cancer treatment ...

Jasper Therapeutics, a biotech looking to make stem cell transplants less taxing and to treat immune-mediated diseases, reported on Monday that its experimental drug helped patients with a chronic ...

Genentech, a drug company, makes bevacizumab, ranibizumab, and faricimab. This company helps patients cover the cost of their products through the Genentech Patient Foundation. If you have ...

Highlighted by Genentech's recent US regulatory submission for trastuzumab–DM1, antibody–drug conjugation technology could be heading for the mainstream in anticancer drug development.

The drug can cause side effects such as reducing platelets ... Kuntz disclosed advisory board (Astellas Pharma, Inc., argenx, ...

Lonza (ticker LONN. S) completed its $1.2 billion purchase of Genentech’s Vacaville campus, considered home of the world’s largest biopharmaceutical manufacturing site, the Swiss drugmaker ...